Getalado, Kenzo E.
HRN: 21-59-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/19/2022
07/26/2022
IV
250mg
Q8
T/C Blunt Abdominal Trauma
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes